* Based on the number of users worldwide for the FreeStyle Libre system compared to the number of users for other leading personal use sensor-based glucose monitoring systems.
† The FreeStyle Libre 2 app is only compatible with certain mobile devices and operating systems. Please check the Compatibility Guide (PDF 69 kB) for more information about device compatibility before using the app. Use of FreeStyle Libre 2 may require registration with LibreView.
‡ The FreeStyle Libre 2 app and the FreeStyle Libre 2 reader have similar but not identical features. Finger pricks are required if glucose readings and alarms do not match symptoms or expectations. The FreeStyle Libre 2 sensor communicates with the FreeStyle Libre 2 reader that started it or the FreeStyle Libre 2 app that started it. The FreeStyle Libre 2 app is only compatible with certain mobile devices and operating systems. Please check the Compatibility Guide (PDF 69 kB) for more information about device compatibility before using the app. Use of FreeStyle Libre 2 may require registration with LibreView.
§ 60-minute warm-up required when applying the sensor.
¶ Sensor is water-resistant in up to 1 metre (3 feet) of water. Do not immerse longer than 30 minutes. Not to be used above 10,000 feet.
** The LibreLinkUp app is only compatible with certain mobile devices and operating systems. Please check for more information about device compatibility before using the app. Use of LibreLinkUp and FreeStyle Libre 2 may require registration with LibreView. The LibreLinkUp mobile app is not intended to be a primary glucose monitor: home users must consult their primary device(s) and consult a healthcare professional before making any medical interpretation and therapy adjustments from the information provided by the app.
References:
- Data on file, Abbott Diabetes Care Inc.
- Fokkert M, et al. Improved well-being and decreased disease burden after 1-year use of flash glucose monitoring (FLARE-NL4). BMJ Open Diabetes Res Care 2019;7(1):e000809. .
- Haak T, et al. Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter, open-label randomized controlled trial. Diabetes Ther 2017;8(1):55-73. .
- Campbell FM, et al. Outcomes of using flash glucose monitoring technology by children and young people with type 1 diabetes in a single arm study. Pediatr Diabetes 2018;19(7):1294-1301. .
STAY CONNECTED